KPV

Overview

KPV is a potent anti-inflammatory tripeptide derived from the C-terminal of alpha-MSH. It exhibits remarkable anti-inflammatory and antimicrobial properties without the pigmentation effects of full α-MSH, making it ideal for inflammation management.

Mechanism of action

Enters cells and inhibits inflammatory pathways at the nuclear level, particularly NF-κB signaling. Reduces pro-inflammatory cytokines (TNF-α, IL-6) without causing immunosuppression like steroids.

Key research findings

• Systemic anti-inflammatory effects
• No pigmentation/tanning effects
• Immune modulation without immunosuppression
• Potential for autoimmune conditions
• Gut health support
• Multiple delivery routes available

Research applications

Inflammation

• Systemic Inflammation — Reduces TNF-α and IL-6 through NF-κB pathway inhibition.
• Autoimmune Modulation — May help balance overactive immune responses in autoimmune conditions.
• Joint Inflammation — Potential benefits for inflammatory arthritis through cytokine reduction.

Gut Health

• IBD Support — Demonstrated benefit in Crohn’s disease and ulcerative colitis models.
• Intestinal Barrier Repair — Helps restore intestinal barrier function.
• Microbiome Balance — Selective antimicrobial activity preserves beneficial gut bacteria.

Skin Health

• Psoriasis/Dermatitis — Topical KPV reduced psoriatic markers by 60% and improved skin barrier function.
• Skin Inflammation — Reduces inflammatory skin conditions without systemic effects.